Plant-based Diet in Older People: What Consequences for Muscle Health?

Overview

This randomized, controlled, two-arm clinical study aims to determine how increasing the proportion of plant-based foods in the diet affects skeletal muscle strength, mass and function, protein metabolism, microbiota and key metabolic markers in healthy older men and women. We hypothesize that diets enriched with animal-based foods will maintain maximal quadriceps strength-the primary outcome of the study-more effectively after the 3-month nutritional intervention than plant-based diets. Proteomic analyses will be performed to identify molecular mechanisms and potential muscle biomarkers reflecting metabolic adaptations of skeletal muscle to plant-enriched diets. In addition, metabolic health markers and micronutrient status will be evaluated to better understand the overall health effects of dietary plant-based transition in older adults.

Detailed description

This exploratory, open-label, randomized, controlled, two-arm clinical study aims to evaluate how increasing the proportion of plant-based foods in the diet affects skeletal muscle health in older adults. The primary objective is to assess the impact of a plant-enriched diet on physical performance, specifically maximal quadriceps strength after a 3-month nutritional intervention.

Secondary objectives are to determine the effects of a plant-enriched diet on: (1) whole-body and muscle protein metabolism, (2) modifications in the skeletal muscle proteome and metabolome, (3) functional capacities, (4) body composition, (5) gut microbiota composition, and (6) sex-related differences in metabolic adaptability. The study will compare diets containing different proportions of plant-based foods in healthy older men and women.

Participants will undergo medical evaluation, nutritional follow-up, body composition measurements, muscle function testing, indirect calorimetry, and biological sampling including blood tests, and microbiota profiling. BBlood samples will be collected for proteomic and metabolomic analyses to identify molecular pathways and potential muscle biomarkers associated with adaptations to plant-enriched diets. In parallel, circulating amino acid concentrations will be measured to assess protein bioavailability, and blood samples will be incubated with skeletal muscle cells to evaluate the anabolic potential of the ingested proteins. Digestive tolerance, micronutrient status, and metabolic health markers will also be monitored.

The procedures are associated with minimal anticipated risks. Blood sampling may cause bruising and indirect calorimetry may result in mild discomfort. Plant-enriched diets may induce transient digestive symptoms or weight loss, which will be closely monitored. Participants experiencing clinically significant weight loss will be withdrawn from the intervention and followed until stabilization.

The findings of this study may strengthen public health recommendations promoting sustainable dietary transitions in older adults and help develop nutritional strategies aimed at maintaining optimal muscle health and supporting healthy aging.

Interventions

• Other Plant-enriched dietary intervention
  Participants follow a diet enriched in plant-based foods with approximately 70% of protein from plant sources and 30% from animal sources for 3 months, with tailored dietary guidance, meal planning support, and compliance monitored through food diaries and periodic follow-up.
• Other Control diet
  Participants follow a standard diet with approximately 70% of protein from animal sources and 30% from plant sources for 3 months, with general nutritional guidance and compliance monitored through food diaries and periodic consultations.

Primary outcome measures

• Maximal Quadriceps Strength [Time frame: Baseline and Month 3]

Secondary outcome measures (9)

• Protein metabolism [Time frame: Baseline and Month 3]
• Short Physical Performance Battery (SPPB) total score [Time frame: Baseline and Month 3]
• Handgrip strength [Time frame: Baseline and Month 3]
• Distance covered during the 6-minute walk test [Time frame: Baseline and Month 3]
• Appendicular lean mass [Time frame: Baseline and Month 3]
• Relative abundance of dominant gut bacterial taxa [Time frame: Baseline and Month 3]
• Sex-specific changes in maximal quadriceps strength [Time frame: Baseline and Month 3]
• Sex-specific changes in serum metabolomic and proteomic profiles [Time frame: Baseline and Month 3]
• Sex-specific changes in appendicular lean mass [Time frame: Baseline and Month 3]

Eligibility criteria

Inclusion criteria

• Men and women aged 65 years and older
• Body Mass Index (BMI) between 18.5 and 30 kg/m² (exclusive)
• Physical activity < 3000 MET-min/week, assessed using the ONAPS-PAQ questionnaire
• Laboratory tests compatible with participation in the study
• Adequate venous status, as assessed by study nurses, allowing catheter placement
• Willingness to participate in study procedures, including indirect calorimetry, functional tests, and assigned dietary intervention (plant-enriched or standard diet)
• Affiliation with the French Social Security system

Exclusion criteria

• Men and women aged 65 years and older
• Body Mass Index (BMI) between 18.5 and 30 kg/m² (exclusive)
• Physical activity < 3000 MET-min/week, assessed using the ONAPS-PAQ questionnaire
• Laboratory tests compatible with participation in the study
• Adequate venous status, as assessed by study nurses, allowing catheter placement
• Willingness to participate in study procedures, including indirect calorimetry, functional tests, and assigned dietary intervention (plant-enriched or standard diet)
• Affiliation with the French Social Security system
• Exclusion period from a previous study or total compensation exceeding €6,000 in the 12 months prior to study initiation (verified through the National Research Volunteer Database)
• Patients under legal guardianship, curatorship, deprived of liberty, or under judicial protection
• Claustrophobia

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation

Randomized

Model

Parallel assignment

Masking

Open label

Primary purpose

Prevention

Study locations

France · 1 center

• CHU de Clermont-Ferrand — Clermont-Ferrand

Identifiers

NCT: NCT07681986 · RBHP 2024 BOIRIE 2 · 2024-A02027-40

Primary sources (government registries)

• ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗